ABACAVIR\LAMIVUDINE: 5,296 Adverse Event Reports & Safety Profile
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
5,296
Total FAERS Reports
463 (8.7%)
Deaths Reported
1,354
Hospitalizations
5,296
As Primary/Secondary Suspect
238
Life-Threatening
94
Disabilities
Active Ingredient: ABACAVIR SULFATE\LAMIVUDINE ·
First Report: 19980518 · Latest Report: 20250819
What Are the Most Common ABACAVIR\LAMIVUDINE Side Effects?
#1 Most Reported
Exposure during pregnancy
593 reports (11.2%)
#2 Most Reported
Pyrexia
450 reports (8.5%)
#3 Most Reported
Rash
390 reports (7.4%)
All ABACAVIR\LAMIVUDINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Exposure during pregnancy | 593 | 11.2% | 79 | 69 |
| Pyrexia | 450 | 8.5% | 101 | 126 |
| Rash | 390 | 7.4% | 88 | 78 |
| Foetal exposure during pregnancy | 373 | 7.0% | 91 | 55 |
| Hypertension | 325 | 6.1% | 83 | 61 |
| Headache | 316 | 6.0% | 82 | 37 |
| Hypersensitivity | 289 | 5.5% | 87 | 51 |
| Pain | 271 | 5.1% | 83 | 25 |
| Thrombocytopenia | 271 | 5.1% | 88 | 29 |
| Off label use | 267 | 5.0% | 92 | 22 |
| Virologic failure | 263 | 5.0% | 6 | 18 |
| Hepatic enzyme increased | 255 | 4.8% | 83 | 24 |
| Drug ineffective | 254 | 4.8% | 92 | 38 |
| Fatigue | 249 | 4.7% | 87 | 36 |
| Upper respiratory tract infection | 248 | 4.7% | 83 | 14 |
| Hyperhidrosis | 243 | 4.6% | 83 | 15 |
| Rheumatoid arthritis | 240 | 4.5% | 85 | 11 |
| Asthma | 239 | 4.5% | 79 | 13 |
| Rash erythematous | 238 | 4.5% | 82 | 10 |
| Nausea | 236 | 4.5% | 18 | 86 |
Who Reports ABACAVIR\LAMIVUDINE Side Effects? Age & Gender Data
Gender: 41.0% female, 59.0% male. Average age: 45.5 years. Most reports from: FR. View detailed demographics →
Is ABACAVIR\LAMIVUDINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 4 | 2 | 4 |
| 2001 | 5 | 0 | 5 |
| 2002 | 5 | 0 | 5 |
| 2003 | 9 | 0 | 8 |
| 2004 | 11 | 0 | 2 |
| 2005 | 11 | 5 | 8 |
| 2006 | 9 | 1 | 7 |
| 2007 | 19 | 0 | 8 |
| 2008 | 17 | 3 | 6 |
| 2009 | 32 | 0 | 5 |
| 2010 | 40 | 2 | 22 |
| 2011 | 87 | 25 | 32 |
| 2012 | 93 | 11 | 44 |
| 2013 | 118 | 3 | 48 |
| 2014 | 389 | 10 | 122 |
| 2015 | 430 | 31 | 178 |
| 2016 | 371 | 28 | 136 |
| 2017 | 314 | 26 | 106 |
| 2018 | 139 | 8 | 56 |
| 2019 | 172 | 26 | 65 |
| 2020 | 109 | 11 | 19 |
| 2021 | 70 | 5 | 17 |
| 2022 | 66 | 1 | 6 |
| 2023 | 23 | 4 | 0 |
| 2024 | 24 | 0 | 8 |
| 2025 | 10 | 1 | 7 |
What Is ABACAVIR\LAMIVUDINE Used For?
| Indication | Reports |
|---|---|
| Hiv infection | 3,366 |
| Product used for unknown indication | 1,242 |
| Antiretroviral therapy | 138 |
| Acquired immunodeficiency syndrome | 78 |
| Hiv test positive | 60 |
| Maternal exposure timing unspecified | 39 |
| Rheumatoid arthritis | 22 |
| Antiviral treatment | 21 |
| Foetal exposure during pregnancy | 19 |
| Acute hiv infection | 17 |
ABACAVIR\LAMIVUDINE vs Alternatives: Which Is Safer?
ABACAVIR\LAMIVUDINE vs ABACAVIR\LAMIVUDINE\ZIDOVUDINE
ABACAVIR\LAMIVUDINE vs ABALOPARATIDE
ABACAVIR\LAMIVUDINE vs ABATACEPT
ABACAVIR\LAMIVUDINE vs ABATACEPT SUBQ /ML
ABACAVIR\LAMIVUDINE vs ABCIXIMAB
ABACAVIR\LAMIVUDINE vs ABEMACICLIB
ABACAVIR\LAMIVUDINE vs ABILIFY
ABACAVIR\LAMIVUDINE vs ABIRATERONE
ABACAVIR\LAMIVUDINE vs ABIRATERONE\ABIRATERONE
ABACAVIR\LAMIVUDINE vs ABOBOTULINUMTOXINA
Official FDA Label for ABACAVIR\LAMIVUDINE
Official prescribing information from the FDA-approved drug label.